Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis

Teresa Bellón1, Virginia Martínez, Baltasar Lucendo

  • 1Research Unit, Hospital Universitario La Paz-FIBHULP, Madrid, Spain. tbellon.hulp@salud.madrid.org

Abstract

Insights

Macrophages (Mϕ) adopt profibrotic (M2) phenotypes, expressing CD163 and producing CC chemokine ligand 18 (CCL18). Elevated CCL18 in peritoneal dialysis patients correlates with peritoneal membrane dysfunction and fibrosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Nephrology

Background:

  • Macrophages (Mϕ) exhibit proinflammatory (M1) or profibrotic (M2) phenotypes based on the cytokine microenvironment.
  • M2 macrophages express CD206 and CD163, and secrete factors like CC chemokine ligand 18 (CCL18).
  • Peritoneal dialysis patients face risks of peritoneal membrane dysfunction, ultrafiltration failure (UFF), and fibrosis due to continuous stress and peritonitis.

Purpose of the Study:

  • To investigate the role of Mϕ phenotypes in peritoneal fibrosis in patients undergoing peritoneal dialysis.
  • To analyze the characteristics and functional capacity of peritoneal effluent Mϕ.
  • To determine the association between Mϕ phenotype, CCL18 production, and peritoneal membrane function.

Main Methods:

  • Flow cytometry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were used to analyze peritoneal effluent Mϕ phenotype.
  • Fibroblast proliferation assays were performed to assess Mϕ's ability to stimulate fibroblast growth.
  • Cytokine production was measured using enzyme-linked immunosorbent assay (ELISA) and immunostaining.

Main Results:

  • Increased frequencies of CD163+ M2 macrophages were observed during peritonitis.
  • Peritoneal macrophages (pMϕ) exhibited M2-like characteristics, including CCL18 mRNA expression.
  • pMϕ-stimulated fibroblast proliferation correlated with CCL18 mRNA levels (r = 0.924, P = 0.016).
  • CCL18 effluent concentrations were linked to decreased peritoneal function (r = 0.724, P < 0.0001) and were higher in patients with UFF and those who developed sclerosing peritonitis.

Conclusions:

  • M2 macrophages may contribute to human peritoneal fibrosis by promoting fibroblast proliferation and producing CCL18.
  • High concentrations of CCL18 are associated with impaired peritoneal membrane function and fibrosis.
  • Targeting M2 macrophages or CCL18 could be a therapeutic strategy for peritoneal dialysis-associated fibrosis.